Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 4
R&D Momentum
75/100
Pipeline Velocity
39/100
Trial Completion Rate
89/100
Pipeline Concentration
22/100
Pipeline Freshness
8/100
Strategic Signals
Activity
Last 14 days
Deep Brain Stimulation Surgery for Movement Disorders
In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging
Natural History Study of Inflammatory and Infectious Diseases of the Nervous System
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 (IN-PASC)
Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques
Evaluation and Treatment of Neurosurgical Disorders
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
Phase I/II Study of Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)